(Q46370993)

21 December 2017

title

Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes (English)

1 reference

21 December 2017

0 references

0 references

Kwame Osei

1

1 reference

21 December 2017

Trudy Gaillard

series ordinal

2

1 reference

21 December 2017

Dara Schuster

series ordinal

3

1 reference

21 December 2017

publication date

1 January 2005

1 reference

21 December 2017

published in

Obesity

1 reference

21 December 2017

volume

13

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

179-185

1 reference

21 December 2017

Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Adiponectin and protection against type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Plasma adiponectin levels in overweight and obese Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Genome-wide linkage analysis of serum adiponectin in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Plasma adiponectin levels are not associated with fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Adiponectin in a native Canadian population experiencing rapid epidemiological transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Ethnic differences in adiponectin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Plasma adiponectin increases postprandially in obese, but not in lean, subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Insulin resistance and associated compensatory responses in african-american and Hispanic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Minimal model analyses of insulin sensitivity and glucose-dependent glucose disposal in black and white Americans: a study of persons at risk for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

Differences in the in vivo insulin secretion and sensitivity of healthy black versus white adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.23

31 March 2020

Identifiers

DOI

10.1038/OBY.2005.23

1 reference

21 December 2017

PubMed ID

15761178

1 reference

21 December 2017